688091 Shanghai Yizhong Pharmaceutical
- 42.71
- -0.26-0.61%
Shanghai Yizhong Pharmaceutical News
Announcement of Shanghai Yizhong Pharmaceutical Co., Ltd. on the inclusion of the core product injectable paclitaxel polymer micelles in the national medical insurance catalogue
Shanghai Yizhong: Announcement of the progress of Shanghai Yizhong Pharmaceutical Co., Ltd. on the repurchase of the company\'s shares through centralized bidding
Announcement of the resolutions of the first interim shareholder meeting of Shanghai Yizhong Pharmaceutical Co., Ltd. in 2024.
Announcement on the share repurchase of Shanghai Yizhong Pharmaceutical Co., Ltd. The top ten shareholders and top ten unrestricted shareholders' shareholdings are as follows: Shareholder holdings:
Shanghai Yizhong_2024 First Interim Shareholders Meeting Materials
Announcement on the share repurchase of Shanghai Yizhong Pharmaceutical Co., Ltd. The top ten shareholders and top ten unrestricted shareholders' shareholdings are as follows: Shareholder holdings:
Notice of Shanghai Yizhong Pharmaceutical Co., Ltd. on the convening of the first temporary shareholders' meeting in 2024.
Reply Announcement on the Information Disclosure Regulatory Inquiry Letter of Shanghai Yizhong Pharmaceutical Co., Ltd. Annual Report for 2023.
Announcement of Shanghai Yizhong Pharmaceutical Co., Ltd. on voluntary disclosure of plans to invest in the construction of a screening and design platform for novel small molecule drugs
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders of Shanghai Yizhong Pharmaceutical Co., Ltd.
Shanghai Yizhong_2023 Annual General Meeting of Shareholders Meeting Materials
Announcement of Shanghai Yizhong Pharmaceutical Co., Ltd. on the 2024 remuneration plan for directors, supervisors and senior management
Announcement of Shanghai Yizhong Pharmaceutical Co., Ltd. on revising and adding some corporate governance systems
Board of Directors Rules of Procedure (April 2024)
Special meeting system for independent directors
Announcement of Shanghai Yizhong Pharmaceutical Co., Ltd. and its subsidiaries on the use of idle own funds for cash management
Announcement of Shanghai Yizhong Pharmaceutical Co., Ltd. on the by-election of independent directors of the second board of directors of the company and the adjustment of the board special committee
Announcement of Shanghai Yizhong Pharmaceutical Co., Ltd. on amending the company's articles of association
Shanghai Yizhong 2023 Internal Control Evaluation Report
Report on the performance of the Audit Committee for the year 2023
Analysis
Price Target
No Data
No Data